Gefitinib Tablets IP 250 Mg Price in Pakistan

Gefitinib Tablets IP 250 Mg Price in Pakistan

Gefitinib Tablets IP 250 Mg Is an Oral Targeted Therapy Prescription Medication Classified as an Egfr Tyrosine Kinase Inhibitor. It Is Primarily Prescribed to Treat Advanced or Metastatic Non-Small Cell Lung Cancer (Nsclc) in Patients With Specific Egfr Gene Mutations. By Blocking Signals That Cause Cancer Cells to Multiply, Gefitinib Slows or Halts Tumor Growth.  

Key Benefits

Targeted Cancer Action: Directly Inhibits Mutated Epidermal Growth Factor Receptor (Egfr) Tyrosine Kinase Enzymes to Suppress Tumor Growth.   
Inhibits Cancer Cell Spread: Helps Shrink Existing Tumors and Reduces the Risk of Cancer Metastasizing to Other Tissues.   
Selective Therapy: Offers Focused Action on Mutated Cancer Cells, Reducing Some Systemic Risks Compared to Traditional Intravenous Chemotherapy.   
Oral Administration: Convenient Daily Tablet Form That Eliminates the Need for Frequent Clinical Hospital Infusions.  

How to Use

Dosage: Take One 250 Mg Tablet Daily Exactly as Prescribed by Your Oncologist.   
Timing: Can Be Taken With or Without Food, Preferably at the Same Time Each Day.   
Administration: Swallow the Tablet Whole With a Full Glass of Water. Do Not Crush, Break, or Chew the Tablet.   
Antacids / Stomach Medicines: Avoid Taking Antacids or H2 Blockers Within 2 Hours Before or 6 Hours After Taking Gefitinib, as They Can Reduce Medication Absorption.  

Key Ingredients

Lactose Monohydrate
Microcrystalline Cellulose
Croscarmellose Sodium
Magnesium Stearate
Film-Coating Agent (Hypromellose, Titanium Dioxide, Polyethylene Glycol, Iron Oxides)